HC Wainwright Issues Pessimistic Outlook for HRMY Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) – HC Wainwright lowered their Q2 2025 earnings estimates for shares of Harmony Biosciences in a note issued to investors on Wednesday, May 7th. HC Wainwright analyst P. Trucchio now anticipates th…

Read Full Article →